Rational design of a multi-valent human papillomavirus vaccine by capsomere-hybrid co-assembly of virus-like particles
Published 2020 View Full Article
- Home
- Publications
- Publication Search
- Publication Details
Title
Rational design of a multi-valent human papillomavirus vaccine by capsomere-hybrid co-assembly of virus-like particles
Authors
Keywords
-
Journal
Nature Communications
Volume 11, Issue 1, Pages -
Publisher
Springer Science and Business Media LLC
Online
2020-06-05
DOI
10.1038/s41467-020-16639-1
References
Ask authors/readers for more resources
Related references
Note: Only part of the references are listed.- Efficacy, safety, and immunogenicity of an Escherichia coli-produced bivalent human papillomavirus vaccine: An interim analysis of a randomized clinical trial
- (2019) You-Lin Qiao et al. JNCI-Journal of the National Cancer Institute
- Immunogenicity noninferiority study of 2 doses and 3 doses of an Escherichia coli-produced HPV bivalent vaccine in girls vs. 3 doses in young women
- (2019) YueMei Hu et al. Science China-Life Sciences
- Rational design of a triple-type human papillomavirus vaccine by compromising viral-type specificity
- (2018) Zhihai Li et al. Nature Communications
- Personalized RNA mutanome vaccines mobilize poly-specific therapeutic immunity against cancer
- (2017) Ugur Sahin et al. NATURE
- An immunogenic personal neoantigen vaccine for patients with melanoma
- (2017) Patrick A. Ott et al. NATURE
- MotionCor2: anisotropic correction of beam-induced motion for improved cryo-electron microscopy
- (2017) Shawn Q Zheng et al. NATURE METHODS
- Stop codon mutagenesis for homogenous expression of human papillomavirus L1 protein in Escherichia coli
- (2017) Daning Wang et al. PROTEIN EXPRESSION AND PURIFICATION
- Characterization of an Escherichia coli -derived human papillomavirus type 16 and 18 bivalent vaccine
- (2017) Ying Gu et al. VACCINE
- Bacterially expressed human papillomavirus type 6 and 11 bivalent vaccine: Characterization, antigenicity and immunogenicity
- (2017) Huirong Pan et al. VACCINE
- Gctf: Real-time CTF determination and correction
- (2016) Kai Zhang JOURNAL OF STRUCTURAL BIOLOGY
- Broad Cross-Protection Is Induced in Preclinical Models by a Human Papillomavirus Vaccine Composed of L1/L2 Chimeric Virus-Like Particles
- (2016) Mathieu Boxus et al. JOURNAL OF VIROLOGY
- The C-Terminal Arm of the Human Papillomavirus Major Capsid Protein Is Immunogenic and Involved in Virus-Host Interaction
- (2016) Zhihai Li et al. STRUCTURE
- Spotlight on the 9-valent HPV vaccine
- (2016) Pier Lopalco Drug Design Development and Therapy
- The U4 Antibody Epitope on Human Papillomavirus 16 Identified by Cryo-electron Microscopy
- (2015) Jian Guan et al. JOURNAL OF VIROLOGY
- A Randomized, Double-Blind, Phase III Study of the Immunogenicity and Safety of a 9-Valent Human Papillomavirus L1 Virus-Like Particle Vaccine (V503) Versus Gardasil® in 9–15-Year-Old Girls
- (2015) Timo Vesikari et al. PEDIATRIC INFECTIOUS DISEASE JOURNAL
- Functional assessment and structural basis of antibody binding to human papillomavirus capsid
- (2015) Xiao Zhang et al. REVIEWS IN MEDICAL VIROLOGY
- Structural comparison of four different antibodies interacting with human papillomavirus 16 and mechanisms of neutralization
- (2015) Jian Guan et al. VIROLOGY
- Lessons learned from successful human vaccines: Delineating key epitopes by dissecting the capsid proteins
- (2015) Xiao Zhang et al. Human Vaccines & Immunotherapeutics
- Identification of Broad-Genotype HPV L2 Neutralization Site for Pan-HPV Vaccine Development by a Cross-Neutralizing Antibody
- (2015) Daning Wang et al. PLoS One
- A Cryo-Electron Microscopy Study Identifies the Complete H16.V5 Epitope and Reveals Global Conformational Changes Initiated by Binding of the Neutralizing Antibody Fragment
- (2014) Hyunwook Lee et al. JOURNAL OF VIROLOGY
- Robust manufacturing and comprehensive characterization of recombinant hepatitis E virus-like particles in Hecolin®
- (2014) Xiao Zhang et al. VACCINE
- Amino acid sequence diversity of the major human papillomavirus capsid protein: Implications for current and next generation vaccines
- (2013) Amina I. Ahmed et al. INFECTION GENETICS AND EVOLUTION
- Efficacy of RG1-VLP Vaccination against Infections with Genital and Cutaneous Human Papillomaviruses
- (2013) Christina Schellenbacher et al. JOURNAL OF INVESTIGATIVE DERMATOLOGY
- A Randomized, Observer-Blinded Immunogenicity Trial of Cervarix® and Gardasil® Human Papillomavirus Vaccines in 12-15 Year Old Girls
- (2013) Eve Draper et al. PLoS One
- Evolution of the Papillomaviridae
- (2013) Koenraad Van Doorslaer VIROLOGY
- RELION: Implementation of a Bayesian approach to cryo-EM structure determination
- (2012) Sjors H.W. Scheres JOURNAL OF STRUCTURAL BIOLOGY
- Antigenic analysis of divergent genotypes human Enterovirus 71 viruses by a panel of neutralizing monoclonal antibodies: Current genotyping of EV71 does not reflect their antigenicity
- (2012) Yixin Chen et al. VACCINE
- Cross-protective responses to human papillomavirus infection
- (2010) ND Christensen et al. Future Virology
- Structural Changes and Dynamic Rheological Properties of Sarcoplasmic Proteins Subjected to pH-Shift Method
- (2010) Panchaporn Tadpitchayangkoon et al. JOURNAL OF AGRICULTURAL AND FOOD CHEMISTRY
- Subunit interactions in bovine papillomavirus
- (2010) M. Wolf et al. PROCEEDINGS OF THE NATIONAL ACADEMY OF SCIENCES OF THE UNITED STATES OF AMERICA
- Trivalent Human Papillomavirus (HPV) VLP vaccine covering HPV type 58 can elicit high level of humoral immunity but also induce immune interference among component types
- (2010) Ting Zhang et al. VACCINE
- AS04, an Aluminum Salt- and TLR4 Agonist-Based Adjuvant System, Induces a Transient Localized Innate Immune Response Leading to Enhanced Adaptive Immunity
- (2009) A. M. Didierlaurent et al. JOURNAL OF IMMUNOLOGY
- Arrangement of L2 within the Papillomavirus Capsid
- (2008) C. B. Buck et al. JOURNAL OF VIROLOGY
Find Funding. Review Successful Grants.
Explore over 25,000 new funding opportunities and over 6,000,000 successful grants.
ExplorePublish scientific posters with Peeref
Peeref publishes scientific posters from all research disciplines. Our Diamond Open Access policy means free access to content and no publication fees for authors.
Learn More